Dex-Moxi
Approved
Approval ID
62ff1da3-7998-676a-e053-2991aa0a4a9f
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Feb 10, 2020
Manufacturers
FDA
Imprimis NJOF, LLC
DUNS: 080431967
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Dexamethasone Phosphate - Moxifloxacin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code71384-512
Product Classification
G
Generic Name
Dexamethasone Phosphate - Moxifloxacin
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateFebruary 10, 2020
FDA Product Classification
INGREDIENTS (2)
DEXAMETHASONE SODIUM PHOSPHATEActive
Quantity: 1 mg in 1 mL
Code: AI9376Y64P
Classification: ACTIR
MOXIFLOXACIN HYDROCHLORIDE MONOHYDRATEActive
Quantity: 5 mg in 1 mL
Code: B8956S8609
Classification: ACTIB